Abnova (Taiwan) Corporation

NT$19.55As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4133Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (4.23%)
Div yield 0.57%
ROE 3.58%
Biotechnology
Beta (5Y) 0.30
PE TTM 26.42
TSR TTM (22.31%)
Mkt cap NT$1.184B
ROIC 2.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$24
23.90%
479.12%
Hold 5|7|9|1|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.43
0.44
0.47
0.52
29.14%
22.24%
23.21%
25.17%
RevenueNT$M
69.31
68.57
67.73
68.28
10.46%
7.81%
7.20%
2.92%
Peers (US$35.75M)
Cap (US$)
PE
37.25M
—
Capital
TTM
5Y
10Y
Leveragex
0.971
0.388
0.390
EBIT/Intx
1.604
0.175
0.159
Own earn%
132.88
75.62
84.76
Sh yield%
41.02
43.44
44.40
Owners
Insiders/Inst%
2.42
52.02
Short interest%
1.30
SBC / revenue%
3.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
0–9
$1 testx
—
Incr. ROIC%
4